<DOC>
	<DOCNO>NCT01965015</DOCNO>
	<brief_summary>The V-Wave atrial-septal shunt implant intend reduction elevate leave atrial filling pressure ( 'Left Atrial Decompression ' ) chronic , New York Heart Association ( NYHA ) class III -IV , Heart Failure ( HF ) patient . This First In Man ( FIM ) study , aim enable first evaluation safety performance V-Wave shunt implant implant Chronic Heart Failure patient . Prospective , open label , single-arm study intra-patient comparison ( i.e . subject ' status compare pre-implant ( baseline ) status .</brief_summary>
	<brief_title>The V-Wave Shunt : FIM Safety Feasibility Study</brief_title>
	<detailed_description>V-Wave Ltd , Israeli base medical device company , develop V-Wave atrial-septal shunt , permanent implant indicate Heart Failure ( HF ) patient elevate Left Atrial filling Pressures ( LAP ) . The V-Wave shunt , develop V-Wave Ltd , design specifically meet need interatrial shunt thus represent dedicated device , implant percutaneously interatrial septum create interatrial communication . This study aim enable first evaluation safety performance V-Wave shunt implant implant Heart Failure patient elevate LAP . Study endpoints choose portray safety ( device relate Major Adverse Cardiac And Neurological Events ) well preliminary performance assess well characterize measure ( e.g. , LAP know associate general state disease importantly leave ventricular ejection fraction cardiac function general ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patient ≥ 18 &lt; 85 year old Patient chronic ischemic nonischemic cardiomyopathy NYHA Class III ambulatory Class IV heart failure despite optimal medical therapy Patient LVEF &gt; 15 % ≤ 40 % Patient elevate Left Atrial Pressure ( LAP ) Patient normal Right Atrial Pressure ( RAP ) BNP NTproBNP level &gt; 300 &gt; 1500 pg/mL , respectively Right Heart Failure Ongoing malignant disease Thromboembolic event within last 6 month Acute chronic renal insufficiency Congenital heart disease Severe pulmonary hypertension Atrial Fibrillation ( persistent/permanent ) Severe Mitral Regurgitation LA Thrombus Deep Vein Thrombosis ( DVT ) Severe restrictive obstructive lung disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Heart Failure ( HF )</keyword>
	<keyword>Left Atrial Pressure</keyword>
</DOC>